(Q39690697)

14 September 2017

title

Triple expression of B7-1, B7-2 and 4-1BBL enhanced antitumor immune response against mouse H22 hepatocellular carcinoma (English)

1 reference

14 September 2017

Guoqiang Li

1

1 reference

14 September 2017

Xiaofeng Wu

2

1 reference

14 September 2017

Feng Zhang

3

1 reference

14 September 2017

Xiangcheng Li

4

1 reference

14 September 2017

Beicheng Sun

5

1 reference

14 September 2017

Yue Yu

6

1 reference

14 September 2017

Aihong Yin

7

1 reference

14 September 2017

Lei Deng

8

1 reference

14 September 2017

Jie Yin

9

1 reference

14 September 2017

Xuehao Wang

10

1 reference

14 September 2017

publication date

19 June 2010

1 reference

Journal of Cancer Research and Clinical Oncology

14 September 2017

published in

1 reference

14 September 2017

volume

137

1 reference

14 September 2017

issue

4

1 reference

14 September 2017

page(s)

695-703

1 reference

https://scigraph.springernature.com/pub.10.1007/s00432-010-0905-9

14 September 2017

exact match

0 references

cites work

4-1BB and Ox40 are members of a tumor necrosis factor (TNF)-nerve growth factor receptor subfamily that bind TNF receptor-associated factors and activate nuclear factor kappaB

1 reference

https://api.crossref.org/works/10.1007%2FS00432-010-0905-9

Temporal segregation of 4-1BB versus CD28-mediated costimulation: 4-1BB ligand influences T cell numbers late in the primary response and regulates the size of the T cell memory response following influenza infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-010-0905-9

A switch in costimulation from CD28 to 4-1BB during primary versus secondary CD8 T cell response to influenza in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-010-0905-9

Co-stimulatory members of the TNFR family: keys to effective T-cell immunity?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-010-0905-9

Expression and function of 4-1BB during CD4 versus CD8 T cell responses in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-010-0905-9

Use of tumour-responsive T cells as cancer treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-010-0905-9

Activation of resting human primary T cells with chimeric receptors: costimulation from CD28, inducible costimulator, CD134, and CD137 in series with signals from the TCR zeta chain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-010-0905-9

Expression of costimulatory molecules CD80 and/or CD86 by a Kaposi's sarcoma tumor cell line induces differential T-cell activation and proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-010-0905-9

21 January 2018

The B7 family revisited

1 reference

https://api.crossref.org/works/10.1007%2FS00432-010-0905-9

It's all Rel-ative: NF-kappaB and CD28 costimulation of T-cell activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-010-0905-9

Up-regulation of c-FLIPshort and reduction of activation-induced cell death in CD28-costimulated human T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-010-0905-9

In vivo tumor co-transfection with superantigen and CD80 induces systemic immunity without tolerance and prolongs survival in mice with hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-010-0905-9

Sorafenib in advanced hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-010-0905-9

The TNF and TNF receptor superfamilies: integrating mammalian biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-010-0905-9

CD28 delivers a unique signal leading to the selective recruitment of RelA and p52 NF-kappaB subunits on IL-8 and Bcl-xL gene promoters.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-010-0905-9

Vaccination with mouse mammary adenocarcinoma cells coexpressing B7-1 (CD80) and B7-2 (CD86) discloses the dominant effect of B7-1 in the induction of antitumor immunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-010-0905-9

Immunostimulatory monoclonal antibodies for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-010-0905-9

Tumour rejection by gene transfer of 4-1BB ligand into a CD80(+) murine squamous cell carcinoma and the requirements of co-stimulatory molecules on tumour and host cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-010-0905-9

A novel antibody-4-1BBL fusion protein for targeted costimulation in cancer immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-010-0905-9

A point mutation in CD28 distinguishes proliferative signals from survival signals

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-010-0905-9

Does the immune system see tumors as foreign or self?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-010-0905-9

Global cancer statistics, 2002

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-010-0905-9

Homeostatic control of lymphocyte survival: potential origins and implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-010-0905-9

B7-mediated costimulation and the immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-010-0905-9

4-1BB costimulatory signals preferentially induce CD8+ T cell proliferation and lead to the amplification in vivo of cytotoxic T cell responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-010-0905-9

Costimulation by CD137/4-1BB inhibits T cell apoptosis and induces Bcl-xL and c-FLIP(short) via phosphatidylinositol 3-kinase and AKT/protein kinase B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-010-0905-9

Renewed interest in cancer immunotherapy with the tumor necrosis factor superfamily molecules

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-010-0905-9

Expression of costimulatory molecules B7-1 (CD80) and B7-2 (CD86) on human hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-010-0905-9

Cutting edge: 4-1BB is a bona fide CD8 T cell survival signal

21 January 2018

1 reference

12 December 2020

Heat shock inhibits radiation-induced activation of NF-kappaB via inhibition of I-kappaB kinase

1 reference

12 December 2020

Amplification of tumor immunity by gene transfer of the co-stimulatory 4-1BB ligand: synergy with the CD28 co-stimulatory pathway

1 reference

12 December 2020

4-1BBL cooperates with B7-1 and B7-2 in converting a B cell lymphoma cell line into a long-lasting antitumor vaccine

1 reference

12 December 2020

The survival of antigen-stimulated T cells requires NFkappaB-mediated inhibition of p73 expression

1 reference

12 December 2020

Role of TNF receptor-associated factor 2 and p38 mitogen-activated protein kinase activation during 4-1BB-dependent immune response

1 reference

12 December 2020

Decreased expression of B7 costimulatory molecules and major histocompatibility complex class-I in human hepatocellular carcinoma

1 reference

12 December 2020

10.1007/S00432-010-0905-9

Identifiers

DOI

1 reference

14 September 2017

1 reference